Covid-19, prise en charge, pistes thérapeutiques et vaccinales

While at the beginning of 2020, the COVID-19 epidemic was spreading at tremendous speed, many scientific teams set to work around the world. The management of severe acute respiratory syndrome coronavirus 2 infections is based on experimental non-specific (symptomatic) or specific (curative) treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Matusik, Élodie, Ayadi, Mériam, Picard, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442000/
https://www.ncbi.nlm.nih.gov/pubmed/32863556
http://dx.doi.org/10.1016/j.actpha.2020.08.007
Descripción
Sumario:While at the beginning of 2020, the COVID-19 epidemic was spreading at tremendous speed, many scientific teams set to work around the world. The management of severe acute respiratory syndrome coronavirus 2 infections is based on experimental non-specific (symptomatic) or specific (curative) treatments. The vaccine will be the key to long-term immunization.

Ejemplares similares